Conditions where obesity-driven inflammation significantly contributes to disease burden, such as rheumatoid arthritis, psoriatic arthritis, and psoriasis, are most likely to show indirect benefit from tirzepatide-induced weight loss
The VPS35 D620N mutation elevates MUL1 protein levels, leading to reduced enzyme activity of complexes I and II, as well as respiratory defects in fibroblasts from PD patients [106]
Lancet Diabetes Endocrinol (2023) 11(2):12938
According to the FDA, approximately 70% of adults in the United States are either overweight or obese
Retatrutide is currently in clinical trials, and while the early results are promising, more data is needed to fully assess its safety
For the first time in years I have control over my drinking and my cravings. For Ian and I, this is the continuation of our lifes work